AcuraStem logo — Patient-Based Therapeutics

AcuraStem

Patient-Based Therapeutics

Founded 2016 United States Pasadena, United States 25 employees Grant Total: $12.00M AI, Biotechnology +2

General Information

Company Name AcuraStem
Founded Year 2016
Location United States Pasadena, United States +1
Founders / Decision Makers
Team member
Employees 25
Industries AI, Biotechnology, Health Care +1
Funding Stage Grant
Social

Get notified when AcuraStem moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AcuraStem

AcuraStem (acurastem.com) is a patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD. Enabled by our ground-breaking iNeuroRx® technology platform - AcuraStem has discovered and is now advancing drug candidates that promise to strongly impact disease progression for most patients, including those for whom the genetic cause of their disease is unknown (i.e. sporadic ALS and FTD patients). The causes of neurodegenerative diseases are complex, and genetically defined forms of disease (e.g. C9ORF72-ALS and FTD) only account for a small percentage of cases. Thus, many scientists didn’t believe it was possible to develop a single effective treatment that could work broadly for all patients. But AcuraStem has shown with its extremely promising therapeutic programs for ALS and FTD that it can be done. Go to acurastem.com to find out more

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 2 •••• •••• 30 Jan 2024
Grant •••••• 1
Investor
25 May 2021
Convertible Note •••••• 2 •••• •••• 08 Nov 2019
Grant •••••• 1 •••• •••• 23 Oct 2019

AcuraStem Alternatives & Competitors

AcuraStem vs

Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s...

Unknown
22 employees
Biotechnology, Health Care
AcuraStem vs
QurAlis
QurAlis United States

Neuro Pioneers on a Quest to Cure

Unknown
89 employees
Biotechnology, Health Care
AcuraStem vs

Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfolding.

Series Unknown
Biotechnology, Health Care

FAQ About AcuraStem

Patient-Based Therapeutics
AcuraStem was founded in 2016.
AcuraStem is headquartered in Pasadena, United States.
AcuraStem operates in the following industries: AI, Biotechnology, Health Care, Health and Wellness.
AcuraStem has approximately 25 employees.
AcuraStem has completed 4 funding rounds, raising a total of $12.00M. The latest funding stage is Grant.
Top alternatives and competitors to AcuraStem include ProMIS™ Neurosciences, Inc., QurAlis, Kineta (Reverse Merger With Yumanity Therapeutics), Libra Therapeutics, Wren Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AcuraStem and ProMIS™ Neurosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AcuraStem and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy